This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Remedy Informatics Selected To Provide Technology Platform For DKMS, The World's Largest Bone Marrow Donor Center





SALT LAKE CITY, Nov. 26, 2013 /PRNewswire/ -- Remedy Informatics, Inc., the leading provider of registry-based informatics software for life sciences research and healthcare delivery, announced that DKMS, the world's largest bone marrow donor center, has selected Remedy's informatics solutions to solidify its position as an innovator and leader of hematopoietic stem cell transplantation worldwide.

(Logo: http://photos.prnewswire.com/prnh/20130213/SF59513LOGO)

"Without question, DKMS is the kind of client where our powerful analytics and pattern recognition technology will have the greatest impact," said Gary Kennedy, Founder & CEO of Remedy Informatics. "We can provide DKMS with solutions that will enable them to improve both donor-recipient matching and, finally, blood cancer patients' chances for survival."

Headquartered in Germany, DKMS is a network of organizations that are actively committed to fighting against blood cancer, diseases of the hematopoietic cell system, and a variety of other forms of cancer. Since 1991, DKMS has been searching for and collecting donor information to match with blood cancer patients around the world. Today, the network boasts more than 3.9 million donors globally and continues to grow each year.

"It is our organization's goal and research focus to give blood cancer patients worldwide a second chance to live," said Prof. Dr. Gerhard Ehninger, DKMS Co-Founder and Director of the Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany. "The only way we can continue to accomplish our mission is by adopting and implementing effective new and innovative technologies. Remedy's software will not only enable us to collect and manage large amounts of donor and patient data, but also to query that data in search of better, more effective treatments—and, one day soon, a cure. We are confident that this partnership will allow us to develop better systems to accomplish our goals and fight this terrible disease."

Remedy's innovative informatics products are built on its flagship Mosaic™ Platform, which offers the industry's most advanced clinical informatics solution. The Mosaic Platform supports Remedy's highly configurable user-friendly registries that are designed to evolve with an organization's changing research needs over time without intervention from IT departments or outside technology consultants.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs